Results 71 to 80 of about 371,996 (314)

1996 UBC First Nations Graduation

open access: yes, 1996
Back Row: Michael Marker, Tina Giguere, Robert Clifton, Tim Vedan, Keven White, Chris Charleson, Iain Dickey, Keith Gosnell, Rodney Sampson, Sheena Seymour, Grace Mirehouse / Middle Row: Petrina Schooner, Sharon Wagner, Cheryl Knockwod, Candice Mattalie,

core  

“First Nations Women Workers' Speak, Write and Research Back: Child Welfare and Decolonizing Stories”

open access: yes, 2005
This research is a similar study to Gold’s (1998) study on the promotion of physical and mental health of mainstream female social workers in child welfare.
Reid, Michelle
core   +1 more source

Cracking the Code: Genotype–Phenotype Correlation Models in Sarcoglycanopathies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Sarcoglycanopathies are among the most severe limb‐girdle muscular dystrophies (LGMD), though milder presentations have been described. These diseases are primarily caused by missense variants, but the limited predictability of their effect on protein maturation, complex formation, and transport has hindered reliable genotype ...
Leonela Luce   +72 more
wiley   +1 more source

“Walk the Land, Before You Talk About the Land”: TEK‐Based Conservation Monitoring Invalidates Caribou Extirpation Status Assigned by British Columbia and Canada

open access: yesConservation Letters
The loss of species represents critical ecological events with far‐reaching implications for conservation biology. Accurate determinations of population status are therefore essential. Erroneous declarations of extinction or extirpation can lead to legal
Bruce R. Muir, Jeff Richert
doaj   +1 more source

UBC First Nations Graduation 1999

open access: yes, 1999
Back Group: Marilyn Iwama, Richard Egan, Ronald Morin / Middle Group: Roberta Harris, Birdy Market, Saylesh Wesley, Mark Point, Rose Lenser, Larry Hanson, Linda Gray, Brenda Payne, Deana Machin, Charlene Crocker, Lori Phillip, Joanne Mussel-Oppenheim ...

core  

“Why is Adoption Like a First Nations’ Feast?: Lax Kw’alaam Indigenizing Adoptions in Child Welfare”

open access: yes, 2010
Have you ever wondered about how to be culturally-sensitive in adoption approaches with Aboriginal people? Have you wanted ideas on how to more effectively engage First Nations adoptive-parents?
Bidgood, Bruce A., Bertsch, Maria
core   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

First Nations Graduates 2002-2003

open access: yes, 2003
Elvin M. N. Boyer, Aaron Bruce, Lisa Adele Caillier, Jeremy Moses, Samaya Jardey, Allen Ronald Benson, Arthur John Jardine, Jessica Celeste Fell, Tracey Booth, Angeline Nyce, Dawana St.

core  

Spiritual Needs of First Nations, Métis and Inuit Foster Parents

open access: yes, 2012
Aboriginal children are overrepresented in foster care and more Aboriginal foster parents are needed. A randomized group of licensed First Nations, Métis and Inuit foster parents in a Canadian jurisdiction were asked about their spiritual needs to foster.
Gerritts, Julie   +4 more
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy